Back to Browse Journals » Clinical Audit » Volume 5

Medication adherence issues in patients: focus on cost

Authors Matsui D

Published Date March 2013 Volume 2013:5 Pages 33—42

DOI http://dx.doi.org/10.2147/CA.S30125

Received 9 November 2012, Accepted 11 January 2013, Published 9 March 2013

Doreen Matsui

Department of Pediatrics and Medicine, University of Western Ontario, London, Ontario, Canada; Children's Hospital, London Health Sciences Centre, London, Ontario, Canada; Children's Health Research Institute, London, Ontario, Canada

Abstract: Advances in drug therapy have resulted in efficacious treatments being available; however, the benefit may be lost if prescribed medications are not taken properly. Unfortunately, poor medication adherence is common and widespread, affecting all age groups and disease conditions. Adherence is a factor in health outcomes of pharmacotherapy with possible failure to achieve therapeutic goals and worsening of illness. Higher health care costs may result from more frequent physician and emergency department visits and increased hospitalization rates. The cost of medications may play a role in whether patients do or do not take their medication with increased cost sharing leading to poorer adherence with prescription drugs. Given the possible adverse consequences of nonadherence, interventions to improve medication-taking behavior are encouraged although not consistently successful. Surprisingly, there is relatively little information on the cost-effectiveness of these interventions and more methodologically sound research is needed in this area. Alternative strategies that have been proposed are value-based insurance design and the use of financial incentives, although the former has not been widely accepted, and the latter is ethically controversial. This article reviews some of the main issues with regards to adherence with drug therapy including some of the cost implications of less than optimal medication adherence.

Keywords: adherence, medication, cost

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Internalization: acute apoptosis of breast cancer cells using herceptin-immobilized gold nanoparticles

Rathinaraj P, Al-Jumaily AM, Huh DS

Breast Cancer: Targets and Therapy 2015, 7:51-58

Published Date: 10 February 2015

Pharmaceutical care – impact on quality of life in patients with type 2 diabetes: a review

Krass I, Dhippayom T

Clinical Audit 2013, 5:17-32

Published Date: 7 March 2013

Outpatient consent practice for varicose vein surgery

Al-Amin A, Taib MF, Aawsaj Y, Rahi A

Clinical Audit 2012, 4:31-35

Published Date: 20 December 2012

Polyacrylonitrile nanofibers coated with silver nanoparticles using a modified coaxial electrospinning process

Yu DG, Zhou J, Chatterton NP, Li Y, Huang J, Wang X

International Journal of Nanomedicine 2012, 7:5725-5732

Published Date: 12 November 2012

Quality of life in patients treated by organ preservation surgery for early laryngeal carcinoma

Allegra E, Franco T, Trapasso S, Aragona T, Domanico R, Garozzo A

Open Access Surgery 2012, 5:27-32

Published Date: 15 October 2012

Lebrikizumab in the personalized management of asthma

Thomson NC, Patel M, Smith AD

Biologics: Targets and Therapy 2012, 6:329-335

Published Date: 14 September 2012

Lack of information and access to advanced treatment for Parkinson’s disease patients

Lökk J

Journal of Multidisciplinary Healthcare 2011, 4:433-439

Published Date: 13 December 2011

Differential effects of nanoselenium doping on healthy and cancerous osteoblasts in coculture on titanium

Phong A Tran, Love Sarin, Robert H Hurt, et al

International Journal of Nanomedicine 2010, 5:351-358

Published Date: 10 May 2010